The Quantellect read.As of Nov 19, 2026, 3 active firms cover XOMA Royalty Corporation: 2 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $39.00 to $76.00, a moderate spread. The average target of $55.00 sits 37% above the current $40.17. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy267%
Neutral133%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$55.00
+36.9% upside
Average target across 3 active firms as of Nov 19, 2026 vs $40.17 current
Highest Target$76.00
Average Target$55.00
Lowest Target$39.00
Detailed analyst forecasts for XOMA
Showing 1–4 of 4 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 2 of 3 active firms rate XOMA a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
XOMA EPS & revenue forecast
EPS · NEXT QUARTER
$0.52
Range $0.52 – $0.52 · 1 analysts · -26% YoY
Next period, 1 analysts expect XOMA Royalty Corporation to earn $0.52 a share (range $0.52 – $0.52), versus $0.70 a year earlier. Full-year consensus is $0.55.
REVENUE · NEXT QUARTER
$16.4M
Range $16.4M – $16.4M · 1 analysts · +76% YoY
Revenue is expected to reach $16.4M (range $16.4M – $16.4M), +75.6% year-over-year. Full-year consensus is $65.0M, rising to $0 next year.
Top analysts covering XOMA Royalty Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XOMA.
#1
Joseph Pantginis
HC Wainwright & Co. · Rank #373
Neutral
$39.00-2.9% to target
Overall win rate
34%
+ Follow
#2
RW
Robert Wasserman
Benchmark · Rank #388
Buy
$50.00+24.5% to target
Overall win rate
41%
+ Follow
#3
David Risinger
Leerink Partners
Buy
$50.00+24.5% to target
Coverage
—
+ Follow
#4
JZ
Jason Zhuang
Leerink Partners
Buy
$50.00+24.5% to target
Coverage
—
+ Follow
#5
EP
Elemer Piros
LUCID CAPITAL MARKETS
Buy
$76.00+89.2% to target
Coverage
—
+ Follow
XOMA stock forecast FAQ
What is XOMA's average 12-month price target?+
The 3 active firms with a live target average $55.00 for XOMA Royalty Corporation over the next 12 months, ranging from a $76.00 high to a $39.00 low, as of Nov 19, 2026.
Is XOMA stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for XOMA?+
The Street-high target is $76.00 (LUCID CAPITAL MARKETS), and the Street-low is $39.00 (HC Wainwright & Co.). The average of all 3 active-firm targets is $55.00.
How many active Wall Street firms cover XOMA?+
3 active firms have a recognized rating on XOMA Royalty Corporation as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering XOMA?+
Among analysts who currently cover XOMA, Joseph Pantginis of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #373). Their current call is Neutral with a $39.00 target.
What is XOMA Royalty Corporation's projected EPS for next quarter?+
The consensus estimate is $0.52 per share (range $0.52 – $0.52) across 1 analysts. Full-year EPS is projected at $0.55, rising to — the following year.
How much revenue is XOMA Royalty Corporation expected to report next quarter?+
Consensus revenue is $16.4M (range $16.4M – $16.4M). Full-year revenue is projected at $65.0M, growing to $0 next year.
Have analysts been upgrading or downgrading XOMA lately?+
As of Nov 19, 2026, 2 of 3 active firms rate XOMA a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XOMA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.